The role of serpinb9/serine protease inhibitor 6 in preventing granzyme B–dependent hepatotoxicity
Open Access
- 29 October 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 46 (5) , 1530-1540
Abstract
Virally infected hepatocytes are resistant to cytotoxic lymphocyte killing by perforin-dependent and granzyme-dependent effector mechanisms. The present studies were designed to examine the role of serine protease inhibitor 6 (SPI-6) in limiting granzyme B–dependent cytotoxic effector mechanisms in the liver. SPI-6–specific small interfering RNA (siRNA) administration to C57Bl/6J (B6) mice elicited transient alanine aminotransferase (ALT) elevations that were not observed in either granzyme B–deficient B6 (B6. gzmb −/−) or natural killer (NK) cell–depleted B6 mice. When SPI-6 expression was abolished by siRNA administration at the time of infection with a recombinant, replication-deficient adenovirus [E1-deleted adenovirus encoding β-galactosidase (AdCMV- LacZ )], earlier and dramatically increased, and earlier ALT elevations were observed in wild-type B6 but not in B6. gzmb −/− or NK cell–depleted mice. When a 3-fold higher dose of AdCMV- LacZ was administered to B6 mice, the coadministration of SPI-6 siRNA resulted in the early onset of lethal, acute liver failure. Of note, the accelerated clearance of AdCMV- LacZ was observed in recipients of SPI-6 siRNA. Conclusion: These results indicate that the regulated expression of SPI-6 in hepatocytes during viral infection or following noninfectious causes of liver injury protects hepatocytes against excessively vigorous granzyme B–dependent killing but may also delay immune clearance of virally infected hepatocytes.Keywords
Funding Information
- National Institutes of Health (R01-DK53933)
This publication has 43 references indexed in Scilit:
- Immunology of hepatitis B virus and hepatitis C virus infectionNature Reviews Immunology, 2005
- Fas and TNFR1, but not cytolytic granule-dependent mechanisms, mediate clearance of murine liver adenoviral infectionHepatology, 2004
- HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus InfectionScience, 2004
- Interferon α2b Decreases Hepatic Micrometastasis in a Murine Model of Ocular Melanoma by Activation of Intrinsic Hepatic Natural Killer CellsInvestigative Ophthalmology & Visual Science, 2004
- Roles of the NKG2D immunoreceptor and its ligandsNature Reviews Immunology, 2003
- The role of TNF–TNFR2 interactions in generation of CTL responses and clearance of hepatic adenovirus infectionJournal of Leukocyte Biology, 2003
- The Granzyme B Inhibitor, PI-9, Is Present in Endothelial and Mesothelial Cells, Suggesting That It Protects Bystander Cells during Immune ResponsesCellular Immunology, 2001
- Adenoviral Vector-Mediated Gene Therapy in the Mouse Lung: No Role of Fas-Fas Ligand Interactions for Elimination of Transgene Expression in Bronchioepithelial CellsHuman Gene Therapy, 1999
- A Cytosolic Granzyme B Inhibitor Related to the Viral Apoptotic Regulator Cytokine Response Modifier A Is Present in Cytotoxic LymphocytesJournal of Biological Chemistry, 1996
- Granzyme B Plays a Critical Role in Cytotoxic Lymphocyte‐induced ApoptosisImmunological Reviews, 1995